Yahoo Web Search

Search results

1. • 

     Wendy Williams’ dream NYC penthouse sold by guardian for a loss after former TV host deemed...

     NY Post via Yahoo News· 2 days ago

     Williams' Financial District condo, replete with luxe trappings, traded hands for a loss only...

2. • 

     Wendy Williams’ NYC penthouse sold for a loss: See inside the luxe Financial District property

     Page Six· 1 day ago

     Boasting more than 2,4000 square feet, Williams’ former apartment features floor-to-ceiling windows...

3. • Alzheimer's Drug Discovery Foundation (ADDF) and Association forFrontotemporal Degeneration (AFTD)...

     WFRV 5 Green Bay· 2 days ago

     This 10-year, $10 million commitment will provide critical funding for frontotemporal dementia (FTD) trials, which will advance new therapies and repurposed ...

4. • 

     This woman has ALS. So did 22 of her relatives. What she wants you to know.

     USA TODAY via Yahoo News· 9 hours ago

     s otherwise sporadic. In Morris' case, 22 people in her family (including second cousins, etc.) have...

5. • Progranulin AAV gene therapy for frontotemporal dementia: translational studies and phase 1/2 trial...

     Nature· 2 days ago

     All mouse studies were performed by PsychoGenics in accordance with approved procedures by the local Institutional Animal Care and Use Committee (IACUC) and the National Institutes of Health ...

6. • Coya Therapeutics Reports First Quarter 2024 Financial Results

     Guru Focus· 5 days ago

     On May 9, 2024, Coya Therapeutics Inc (COYA, Financial), a trailblazer in biologics for enhancing regulatory T cell function, disclosed its financial outcomes for the first quarter ended March ...

7. • Study uncovers protein interactions as a potential path for ALS cure

     Medical Xpress· 1 day ago

     The research, which illustrates how protein interactions can preserve or prevent the nerve cell death that is a hallmark of ALS, is the culmination of decades of Western research backed by the ...

8. • 

     Canadian researchers unlock potential 'cure' for ALS – KION546

     KION 46 Salinas· 1 day ago

     New research out of London, Ont.’s Western University is shedding light on a potential cure for ALS,...

9. • 

     Takeda pays AC Immune $100M upfront for Alzheimer's drug as phase 2 readout nears

     FierceBiotech· 3 days ago

     Takeda may be paring back its R&D pipeline in the name of efficiency, but the Japanese pharma has...

10. • Small Business - The Andalusia Star-News | The Andalusia Star-News

      The Andalusia Star-News· 7 days ago

      Company to host a webcast today at 8:30 a.m. Eastern Time NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated